Enasidenib Mesylate and Insulin glulisine Subcutaneous
Determining the interaction of Enasidenib Mesylate and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: enasidenib
Brand name: Idhifa, Idhifa
Synonyms: Enasidenib
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Enasidenib Mesylate-Insulin human inhaled Inhalation
- Enasidenib Mesylate-Insulin human regular Injection
- Enasidenib Mesylate-Insulin inhalation
- Enasidenib Mesylate-Insulin isophane
- Enasidenib Mesylate-Insulin isophane and insulin regular
- Enasidenib Mesylate-Insulin lispro
- Insulin glulisine Subcutaneous-EnBrace HR
- Insulin glulisine Subcutaneous-Enbrel
- Insulin glulisine Subcutaneous-Enbrel (Etanercept Prefilled Syringes)
- Insulin glulisine Subcutaneous-Enbrel (Etanercept Vials)
- Insulin glulisine Subcutaneous-Enbrel SureClick
- Insulin glulisine Subcutaneous-Encora